The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: azathioprine     Quarter: 2016Q3

Total Drug/Injury Combinations: 480     Number of Pages: 24

DRUGNAME PT EventCount
AZATHIOPRINE. Pierre Robin syndrome 6 view events
AZATHIOPRINE. Post transplant lymphoproliferative disorder 6 view events
AZATHIOPRINE. Product use issue 6 view events
AZATHIOPRINE. Strabismus congenital 6 view events
AZATHIOPRINE. Abortion spontaneous 5 view events
AZATHIOPRINE. Arthralgia 5 view events
AZATHIOPRINE. Asthenia 5 view events
AZATHIOPRINE. Diabetes mellitus 5 view events
AZATHIOPRINE. Dizziness 5 view events
AZATHIOPRINE. Extrapulmonary tuberculosis 5 view events
AZATHIOPRINE. Hepatotoxicity 5 view events
AZATHIOPRINE. Infection 5 view events
AZATHIOPRINE. Inflammation 5 view events
AZATHIOPRINE. Interstitial lung disease 5 view events
AZATHIOPRINE. Neoplasm malignant 5 view events
AZATHIOPRINE. Night sweats 5 view events
AZATHIOPRINE. Premature baby 5 view events
AZATHIOPRINE. Rheumatoid arthritis 5 view events
AZATHIOPRINE. Vomiting 5 view events
AZATHIOPRINE. Acute monocytic leukaemia 4 view events

Total Drug/Injury Combinations: 480     Number of Pages: 24

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)